Cargando…

STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors

Detalles Bibliográficos
Autores principales: Akporiaye, Emmanuel T, Tucker, Christopher, Triplett, Todd, Garrison, Kendra, Sun, Lihong, Ling, Leona, Weinberg, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991171/
http://dx.doi.org/10.1186/2051-1426-1-S1-P68
_version_ 1782312387010887680
author Akporiaye, Emmanuel T
Tucker, Christopher
Triplett, Todd
Garrison, Kendra
Sun, Lihong
Ling, Leona
Weinberg, Andrew
author_facet Akporiaye, Emmanuel T
Tucker, Christopher
Triplett, Todd
Garrison, Kendra
Sun, Lihong
Ling, Leona
Weinberg, Andrew
author_sort Akporiaye, Emmanuel T
collection PubMed
description
format Online
Article
Text
id pubmed-3991171
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39911712014-05-01 STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors Akporiaye, Emmanuel T Tucker, Christopher Triplett, Todd Garrison, Kendra Sun, Lihong Ling, Leona Weinberg, Andrew J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991171/ http://dx.doi.org/10.1186/2051-1426-1-S1-P68 Text en Copyright © 2013 Akporiaye et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Akporiaye, Emmanuel T
Tucker, Christopher
Triplett, Todd
Garrison, Kendra
Sun, Lihong
Ling, Leona
Weinberg, Andrew
STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title_full STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title_fullStr STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title_full_unstemmed STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title_short STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors
title_sort stat3 signaling is required for anti-ox40/tgf-β receptor blockade-mediated regression of large established tumors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991171/
http://dx.doi.org/10.1186/2051-1426-1-S1-P68
work_keys_str_mv AT akporiayeemmanuelt stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT tuckerchristopher stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT tripletttodd stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT garrisonkendra stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT sunlihong stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT lingleona stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors
AT weinbergandrew stat3signalingisrequiredforantiox40tgfbreceptorblockademediatedregressionoflargeestablishedtumors